The role of radiation in managing high-risk localized prostate cancer [Video]

Sophia Kamran, MD, Massachusetts General Hospital, Boston, MA, gives an overview of treatment options for high-risk localized prostate cancer, which typically consists of surgery or radiotherapy and androgen deprivation therapy (ADT). Findings from the GETUG-AFU 18 trial (NCT00967863) of radiotherapy and ADT demonstrated the benefits in overall survival of dose escalation of radiotherapy. However, more research is needed to elucidate quality of life and toxicity in patients. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.